Analysts Set Prestige Consumer Healthcare Inc. (NYSE:PBH) Price Target at $93.33

Prestige Consumer Healthcare Inc. (NYSE:PBH) has been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $93.33.

Several research analysts have recently commented on PBH shares. Oppenheimer lifted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. StockNews.com lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, April 8th. Royal Bank of Canada upped their price objective on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a research report on Friday, March 21st. Finally, DA Davidson lifted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the company’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. This represents a 8.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Prestige Consumer Healthcare

A number of institutional investors have recently made changes to their positions in the stock. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare in the 4th quarter valued at about $27,000. CIBC Private Wealth Group LLC raised its holdings in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock valued at $34,000 after acquiring an additional 152 shares during the last quarter. Headlands Technologies LLC acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth $40,000. McIlrath & Eck LLC lifted its position in Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock worth $75,000 after buying an additional 154 shares during the period. Finally, Johnson Financial Group Inc. purchased a new stake in Prestige Consumer Healthcare in the 4th quarter valued at about $93,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Down 1.5 %

Shares of PBH stock opened at $80.90 on Friday. The company has a market cap of $4.01 billion, a price-to-earnings ratio of 18.95, a PEG ratio of 2.69 and a beta of 0.47. The stock has a 50 day simple moving average of $84.56 and a 200-day simple moving average of $79.97. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare has a 1-year low of $62.35 and a 1-year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, equities research analysts expect that Prestige Consumer Healthcare will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.